Heghine Khachatryan: Endometriosis Is Not Only a Pain Disorder
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology and Oncology Center, shared a post on LinkedIn:
”Endometriosis is not only a pain disorder.
It should increasingly be recognized as a systemic clinical condition, associated not only with chronic pelvic pain, dysmenorrhea, and infertility, but also with fatigue, significant impairment in quality of life, heavy menstrual bleeding, and iron deficiency.
Recent international evidence suggests that women with endometriosis are at increased risk of iron deficiency, and in many cases, low ferritin may be present even before overt anemia develops.
This requires a shift in our clinical thinking.
When a patient presents with:
- heavy menstrual bleeding
- pronounced fatigue
- pelvic pain
- subfertility
- and ‘borderline normal’ hemoglobin
we should not limit management to symptomatic pain control alone.
A comprehensive evaluation should include:
- ferritin levels
- complete blood count indices
- assessment of iron deficiency
- evaluation for abnormal uterine bleeding / adenomyosis overlap
- and the overall inflammatory and functional burden of disease
Modern management of endometriosis is multidimensional:
- early clinical suspicion
- targeted imaging
- individualized management of pain and bleeding
- timely identification and correction of iron deficiency
- and, when appropriate, consideration of newer therapeutic options, including oral GnRH antagonists in selected patients
The key message is clear:
Low ferritin in a woman with endometriosis is not a minor laboratory finding.
It may represent a clinically meaningful indicator of:
- ongoing blood loss
- disease burden
- and unrecognized functional compromise
Contemporary endometriosis care must go beyond lesion detection and focus on: iron status, bleeding burden, and the full impact on a woman’s daily life.”
Other posts featuring Heghine Khachatryan on Hemostasis Today.
-
May 27, 2026, 09:58Omid Seidizadeh: Take The EAHAD Survey on Access to Diagnosis and Treatment for VWD Europe
-
May 27, 2026, 09:51Richard Benjamin: RedeS Phase III Trial Reaches Major Milestone in Advancing Pathogen-Reduced RBCs for Transfusion
-
May 27, 2026, 04:47Daniel Torrent: The Overlooked Epidemic of Post-Thrombotic Syndrome
-
May 27, 2026, 04:45Graziella Pompei: Is Aspirin Still a Valid Alternative to Clopidogrel in PCI with DES Implantation?
-
May 27, 2026, 04:40Kausik Ray: Phase 1 Trial Highlights Anti-Inflammatory Effects of Ruvonoflast
-
May 27, 2026, 04:29Francisco Chacón-Lozsán: High-Sensitivity Troponin and the Evolving Management of NSTEMI
-
May 27, 2026, 04:14Michael R. Jaff: HI-PEITHO Trial and NEWS Score Insights on Advances for Intermediate-Risk Pulmonary Embolism
-
May 26, 2026, 16:45Ashley George: Take the Leap for Thrombosis UK
-
May 26, 2026, 16:40Hamed Helisaz: Machine Learning for Detecting Missing Heart Medications